GK
GSK icon

Graney & King’s GSK GSK Stock Holding History

Graney & King’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$130K Buy
2,485
+20
+0.8% +$1.06K 0.05% 91
2026
Q1 		$136K Buy
2,465
+21
+0.9% +$1.14K 0.07% 83
2025
Q4 		$120K Buy
2,444
+22
+0.9% +$1.03K 0.07% 85
2025
Q3 		$105K Buy
2,422
+125
+5% +$4.88K 0.07% 87
2025
Q2 		$88.2K Buy
2,297
+27
+1% +$1.03K 0.06% 92
2025
Q1 		$88K Buy
2,270
+21
+0.9% +$769 0.07% 85
2024
Q4 		$76K Buy
+2,249
New +$81K 0.06% 95

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Graney & King's GSK Position: Q2 2026 in Review

Graney & King increased its GSK (GSK) stake by 0.81% in Q2 2026, buying an estimated $1.06K and bringing the position to 2,485 shares worth $130K. The position accounts for 0.05% of the portfolio, ranked #91.

Graney & King first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. The position peaked at $136K in Q1 2026. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Graney & King held 2,485 shares of GSK worth $130K as of Q2 2026.
  • Graney & King bought 20 GSK shares in Q2 2026, an estimated $1.06K.
  • GSK made up 0.05% of Graney & King's portfolio in Q2 2026, its #91 holding.
  • Graney & King first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
  • Graney & King's GSK position peaked at $136K in Q1 2026.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Graney & King's 13F filing for Q2 2026, filed 7 Aug 2026.